Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.8M
-
Number of holders
-
635
-
Total shares
-
75.3M
-
Shares change
-
+28.8K
-
Total reported value, excl. options
-
$14.4B
-
Value change
-
+$29.9M
-
Put/Call ratio
-
1.32
-
Number of buys
-
246
-
Number of sells
-
-324
-
Price
-
$191.39
Significant Holders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) as of Q1 2018
648 filings reported holding IDXX - IDEXX LABORATORIES INC /DE - Common Stock as of Q1 2018.
IDEXX LABORATORIES INC /DE - Common Stock (IDXX) has 635 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 75.3M shares
of 80.8M outstanding shares and own 93.14% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8.88M shares), BlackRock Inc. (6.61M shares), BAMCO INC /NY/ (4.47M shares), Fundsmith LLP (4.43M shares), STATE STREET CORP (3.51M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.19M shares), RENAISSANCE TECHNOLOGIES LLC (2.09M shares), AMERIPRISE FINANCIAL INC (1.7M shares), BLAIR WILLIAM & CO/IL (1.62M shares), and Neuberger Berman Group LLC (1.62M shares).
This table shows the top 635 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.